Description
LGD-4033 Ligandrol Capsules Research Overview
Disclaimer: This product is supplied by Iron Mountain Labz and is intended for laboratory research use only. It is not intended for medical use or human consumption.
Preview
LGD-4033 (Ligandrol) is a SARM from Ligand Pharmaceuticals. It is classified as a nonsteroidal oral compound designed to bind selectively to androgen receptors in skeletal muscle and bone tissue. The compound is studied under conditions such as muscle wasting, osteoporosis, age-related muscle loss, and hip fracture recovery.
In early clinical studies involving healthy young test subjects, short-term administration produced dose-dependent increases in lean body mass within 21 days. These findings helped establish safety data and demonstrated strong anabolic activity with selective targeting of muscle tissue and bone mineral density.
| Property | Details |
| Product Name | LGD-4033 (Ligandrol) Capsules |
| CAS Number | 1165910-22-4 |
| Molecular Weight | 338.25 g/mol |
| Chemical Formula | C14H12F6N2O |
| IUPAC Name | 4-[(2R)-2-[(1R)-1,1,1-trifluoropropan-2-yl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile |
| Form | White to off-white capsules |
| Purpose | LGD-4033 Ligandrol Capsules are not supplements. They cannot diagnose, treat, cure, or prevent any condition. This product is intended strictly for laboratory research use only. |
Working Mechanism
LGD 4033 binds with high affinity to the selective androgen receptor located primarily in skeletal muscle and bone. Since it’s attached, it activates anabolic gene transcription pathways. These result in increased muscle protein synthesis, nitrogen retention, and support lean mass accumulation. Preclinical studies also suggest improvements in bone mineral density, supporting research in osteoporosis and muscle wasting models. This shows that LGD 4033 produces targeted anabolic activity in muscle and bone without the broader systemic androgenic effects.
Why Consider LGD-4033 Ligandrol for Research?
Researchers may consider LGD-4033 Ligandrol Capsules based on its intended research application, available specifications, and supporting documentation.
- LGD-4033 (Ligandrol) has a Batch Number: ML-LG563
- Purity (HPLC): 99.8% (USP <621>)
- Assay: 98.7% (USP <821>, within 97.0–103.0% spec)
- Endotoxin: <0.2 EU/mg (Limit ≤5 EU/mg, USP <85>)
- Microbial Limits: No growth detected (USP <81>)
- Heavy Metals: <5 ppm (Limit ≤10 ppm, USP <231>)
- Residual Solvents (GC): 0.1% (Limit ≤0.5%, USP <467>)
- Soluble in DMSO (USP <1231>)
- Shipping and delivery details are determined by the selected vendor and should be verified before purchase.
Note: Researchers studying this compound may pair it with other SARMs, such as Ostarine MK-2866 and RAD-140 Testolone, so they get more research findings.
Ask more about this product. Contact help@ironmountainlabz.com
FAQs
Is LGD 4033 the same as anabolic steroids?
It’s not the same. LGD 4033 is a selective androgen receptor modulator that targets specific tissues with high affinity.
Does it affect bone tissue?
There is preclinical research that suggests positive effects on bone mineral density. That is why it is mentioned mostly in osteoporosis and hip fracture research.
Are long-term effects established?
They are still under research. Some studies say hormone suppression at certain dose levels.
How does it compare to other SARMs?
Compared to Ostarine, LGD 4033 generally shows stronger anabolic effects in lean mass studies.
Why Consider LGD-4033 Ligandrol Capsules for Research?
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
